Microbial Catabolism of Nicotine and Its Derivatives

Microbial catabolism of nicotine and its derivatives encompasses a suite of enzymatic pathways by which bacteria transform the tobacco alkaloid into less toxic intermediates and, ultimately, into central metabolites. Two primary routes have been characterised: the pyridine pathway, initiated by hydroxylation of the pyridine ring, and the pyrrolidine pathway, beginning with oxidation of the pyrrolidine ring. A hybrid pathway combining elements of both has also been described, expanding the metabolic diversity available to soil and rhizosphere bacteria. Beyond fundamental environmental detoxification, these pathways offer routes to valuable chemical precursors and therapeutic enzymes. Recent advances include enzyme engineering to improve oxygen use, genome‐driven discovery of novel gene clusters, and applications in soil bioremediation and biotransformation of tobacco waste. Taken together, microbial nicotine catabolism represents a dynamic field at the interface of environmental microbiology, enzymology and green chemistry, with global relevance for pollution control, public health and sustainable biomanufacturing.

Research from Nature Portfolio

Recent studies have applied directed evolution to a flavin‐dependent nicotine oxidoreductase, enhancing its ability to use molecular oxygen as electron acceptor. Variants engineered around a putative oxygen channel exhibit tenfold higher nicotine‐degrading activity in vitro and in vivo, overcoming limitations of cofactor dependence and paving the way for enzyme‐based therapies or biocatalytic processes.

Genome and transcriptome analyses of a soil bacterium capable of hybrid nicotine degradation have elucidated a genomic island harbouring novel gene clusters. Comparative expression profiling under nicotine versus standard growth conditions revealed coordinated regulation of transporters, oxidoreductases and electron‐transfer components. This work uncovers the evolutionary mosaicism of the hybrid pathway and identifies potential targets for metabolic engineering.

Microbial Catabolism of Nicotine and Its Derivatives publication trend

The graph below shows the total number of articles in microbial catabolism of nicotine and its derivatives across all publications each year (not limited to Nature Index journals).

Technical terms

Pyridine pathway: A route of nicotine degradation initiated by hydroxylation of the pyridine ring, leading to successive ring cleavage and oxidation steps.

Pyrrolidine pathway: A degradation route beginning with oxidation of the pyrrolidine ring of nicotine, proceeding through a series of dehydrogenation and hydrolysis reactions.

Hybrid pathway: A composite nicotine‐catabolic route combining initial reactions of both pyridine and pyrrolidine pathways, found in certain soil bacteria.

Flavoenzyme: An enzyme containing a flavin cofactor (FAD or FMN) that catalyses redox reactions, often critical in alkaloid degradation.

Genomic island: A contiguous DNA segment acquired by lateral gene transfer, often encoding specialised metabolic functions such as nicotine catabolism.

Directed evolution: A laboratory technique that mimics natural selection to improve enzyme properties by iterative rounds of mutation and screening.

References

1. The enzymes of microbial nicotine metabolism. Beilstein Journal of Organic Chemistry (2018).
2. Directed evolution unlocks oxygen reactivity for a nicotine-degrading flavoenzyme. Nature Chemical Biology (2023).
3. Genomic and transcriptomic analyses of Agrobacterium tumefaciens S33 reveal the molecular mechanism of a novel hybrid nicotine-degrading pathway. Scientific Reports (2017).
4. Cultivation and application of nicotine-degrading bacteria and environmental functioning in tobacco planting soil. Bioresources and Bioprocessing (2023).
5. Rational design of a flavoenzyme for aerobic nicotine catabolism. mBio (2024).
6. Physiology of a Hybrid Pathway for Nicotine Catabolism in Bacteria. Frontiers in Microbiology (2020).
7. Sustainable production of valuable compound 3-succinoyl-pyridine by genetically engineering Pseudomonas putida using the tobacco waste. Scientific Reports (2015).